News
Forum
Contacts
UK
EN
About us
Cystic fibrosis
Focus of activity
Useful information
Donate
About us
cystic fibrosis
FOCUS OF ACTIVITY
USEFUL INFORMATION
News
Forum
Contacts
UK
EN
New targeted drug Alyftrek from Vertex Pharmaceuticals
Posted on
13.07.2025
by
cf-ukraine
Post navigation
Previous:
Effect of ELX/TEZ/IVA on infections and antibiotic use in cystic fibrosis.
Next:
Prime Medicine receives $24 million to develop gene-editing therapy for cystic fibrosis
